Skip to main content

Guidance and regulation

Skip to results
1,102 results sorted by Most viewed
From UK Health Security Agency (UKHSA)
  • An evidence-based framework to inform local prioritisation decisions for sexually transmitted infection (STI) control.

  • Crimean-Congo haemorrhagic fever (CCHF) is a viral haemorrhagic fever (VHF) caused by a virus of the Nairoviridae family.

  • Patient group direction (PGD) template to support the provision of MenACWY vaccine to individuals with underlying medical conditions.

  • Information on respiratory syncytial virus (RSV) and the benefits of vaccination for pregnant women and their babies and a poster and stickers to promote the vaccination to pregnant women.

  • Cholera immunisation information for public health professionals.

  • The epidemiology, symptoms, diagnosis and management of Nipah virus infections.

  • Japanese encephalitis immunisation information for public health professionals.

  • PGD template for administering hexavalent vaccine following national recommendations and the routine childhood immunisation programme.

  • The Heat-Health Alerting system is part of the Weather-Health Alerting system, which is operated by UKHSA in partnership with the Met Office. This is part of the alerts and warnings section of the hazard: heat.

  • Information on the investigation, diagnosis and management of a pregnant woman who has, or is exposed to, viral rash illness.

  • This guidance describes symptoms of mpox and epidemiological criteria to help inform testing and reporting of suspected cases.

  • A guide to UKHSA's bacteriology reference department (BRD), its units and the tests and services they provide.

  • Poster promoting the availability of the meningococcal capsular group B (MenB) vaccine.

  • The alerting system provides an early warning when adverse temperatures are likely to impact on the health and wellbeing of the population.

  • This page provides an overview of mpox epidemiology, indicating where there may be a risk of clade I and clade II mpox exposure.

  • UK Health Security Agency's immunoglobulin handbook, providing guidance on administering immunoglobulin to prevent serious disease.

  • Tuberculosis (TB) screening and early detection methods, for professionals working with at-risk populations in the UK.

  • Advice and guidance on the health needs of migrant patients for healthcare practitioners.

  • Information to assist with the laboratory diagnosis of Lyme disease and requirements for sample submission.

  • The Brucella Reference Unit (BRU) provides laboratory diagnostic and clinical management services for Brucella species.